LONDON, UNITED KINGDOM / ACCESS Newswire / March 24, 2025 / Hemogenyx Pharmaceuticals plc is pleased to announce that the first ... safety assessment. Early signs of efficacy are encouraging. The ...

First Patient Treated with HG-CT-1 CAR-T Therapy Passes Initial Safety Tests Hemogenyx Pharmaceuticals plc is pleased to announce that the first patient has been successfully treated as part of ...

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF REGULATION 2014/596/EU WHICH IS PART OF ...